Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate

Carcinogenesis

Volumn 27, Issue 11, 2006, Pages 2316-2321

  Quievryn, George ^a,b   Messer, Joseph ^a,c   Zhitkovich, Anatoly ^a  

^a BROWN UNIVERSITY   (United States)

^b Architecture of Drägerwerk AG and Co KGaA   (United States)

^c Genzyme   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHELATING AGENT; CHROMIC ACID; CHROMIUM; CHROMIUM DERIVATIVE; DICHLORODIHYDROFLUORESCEIN DIACETATE; DNA;

ARTICLE; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPLETION; DISSOCIATION; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA STRAND BREAKAGE; GENE REPLICATION; GENOTOXICITY; METAL BINDING; METAL METABOLISM; MOLECULAR STABILITY; MUTAGENESIS; MUTAGENICITY; OXIDATION; PLASMID; PRIORITY JOURNAL; REDUCTION; SHUTTLE VECTOR;

ASCORBIC ACID; CHELATING AGENTS; CHROMATES; CHROMIUM; DNA ADDUCTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MODELS, CHEMICAL; MUTAGENESIS; MUTAGENS; OXIDANTS; PLASMIDS;

EID: 33750490455     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl076     Document Type: Article

References (37)

1. Langard,S. (1990) One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med., 17, 189-215.
2. Sorahan, T., Burges,D.C., Hamilton,L. and Harrington,J.M. (1998) Lung cancer mortality in nickel/chromium platers, 1946-95. Occup. Environ. Med., 55, 236-242.
3. Gibb,H.J., Lees,P.S.J., Pinsky,P.F. and Rooney,B.C. (2000) Lung cancer among workers in chromium chemical production. Am. J. Ind. Med., 38, 115-126.
4. Zhitkovich,A. (2005) Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol., 18, 3-11.
5. Standeven,A.M. and Wetterhahn,K.E. (1991) Ascorbate is the principal reductant of chromium(VI) in rat liver and kidney ultrafiltrates. Carcinogenesis, 12, 1733-1737.
6. Standeven,A.M. and Wetterhahn,K.E. (1992) Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis, 13, 1319-1324.
7. Quievryn,G., Peterson,E., Messer,J. and Zhitkovich,A. (2003) Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry, 42, 1062-1070.
8. Sugden,K.D. and Stearns,D.M. (2000) The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer. J. Environ. Pathol. Toxicol. Oncol., 19, 215-230.
9. Goodgame,D.M.L. and Joy,M.A. (1987) EPR study of the Cr(V) and radical species produced in the reduction of Cr(VI) by ascorbate. Inorg. Chim. Acta, 135, 115-118.
10. Stearns,D.M. and Wetterhahn,K.E. (1994) Reaction of Cr(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem. Res. Toxicol., 7, 219-230.
11. Lay,P.A. and Levina,A. (1998) Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: Implications for chromium-induced genotoxicities. J. Am. Chem. Soc., 120, 6704-6714.
12. Casadevall,M., da Cruz Fresco,P. and Kortenkamp,A. (1999) Chromium(VI)-mediated DNA damage: Oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chem. Biol. Interact., 123, 117-132.
13. O'Brien,T., Mandel,H.G., Pritchard,D.E. and Patierno,S.R. (2002) Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry, 41, 12529-12537.
14. Slade,P.G., Hailer,M.K., Martin,B.D. and Sugden,K.D. (2005) Guanine-specific oxidation of double-stranded DNA by Cr(VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2′-deoxyguanosine. Chem. Res. Toxicol., 18, 1140-1149.
15. De Flora,S. (2000) Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis, 21, 533-541.
16. Zhitkovich,A., Voitkun,V. and Costa,M. (1995) Glutathione and free amino acids form stable adducts with DNA following expense of intact mammalian cells to chromate. Carcinogenesis, 16, 907-913.
17. Quievryn,G., Messer,J. and Zhitkovich,A. (2002) Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry, 41, 3156-3167.
18. Park,R.M., Bena,J.F., Stayner,L.T., Smith,R.J., Gibb,H.J. and Lees,P.S, (2004) Hexavalent chromium and lung cancer in the chromate industry: A quantitative risk assessment. Risk Anal., 24, 1099-1108.
19. Zhitkovich,A., Messer,J. and Shrager,S. (2000) Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem. Res. Toxicol., 13, 1114-1124.
20. Parris,C.N. and Seidman,M.M. (1992) A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene, 117, 1-5.
21. Ariza,R.R., Roldan-Arjona,T., Hera,C. and Pueyo,C. (1993) A method for selection of forward mutations in supF gene carried by shuttle-vector plasmids. Carcinogenesis, 14, 303-305.
22. Hanahan,D., Jessee,J. and Bloom,F.R. (1991) Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol., 204, 83-88.
23. Zhitkovich,A., Song,Y., Quievryn,G. and Voitkun,V. (2001) Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry, 40, 549-560.
24. Messer,J., Reynolds,M., Stoddard,L. and Zhitkovich,A. (2006) Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells. Free Radic. Biol. Med., 40, 1981-1992.
25. Quievryn,G., Goulart,M., Messer,J. and Zhitkovich,A. (2001) Reduction of Cr(VI) by cysteine: Significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol. Cell. Biochem., 222, 107-118.
26. Martin,B.D., Schoenhard,J.A. and Sugden,K.D. (1998) Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2′,7′-dichlorofluorescin and dihydrorhodamine. Chem. Res. Toxicol., 11, 1402-1410.
27. da Cruz Fresco,P. and Kortenkamp,A. (1994) The formation of DNA cleaving species during the reduction of chromate by ascorbate. Carcinogenesis, 15, 1773-1778.
28. da Cruz Fresco,P., Shacker,F. and Kortenkamp,A. (1995) The reductive conversion of chromium(VI) by ascorbate gives rise to apurinic/ apyrimidinic sites in isolated DNA. Chem. Res. Toxicol., 8, 884-890.
29. Zhang,Z. and Lay,P.A. (1996) EPR spectroscopic studies of the reactions of Cr(VI) with L-ascorbic acid, L-dehydroascorbic acid, and 5,6-o-isopropylidene-L-ascorbic acid in water. Implications for chromium(VI) genotoxicity. J. Am. Chem. Soc., 118, 12624-12637.
30. Lay,P.A. and Levina,A. (1998) Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: Implications for chromium-induced genotoxicities. J. Am. Chem. Soc., 120, 6704-6714.
31. Shi,X., Ding,M., Ye,J., Wang,S., Leonard,S.S., Zang,L., Castranova,V., Vallyathan,V., Chiu,A., Dalal,N. and Liu,K. (1999) Cr(IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions. J. Inorg. Biochem., 75, 37-44.
32. Caldecott,K.W. (2001) Mammalian DNA single-strand break repair: An X-ra(y)ted affair. Bioessays, 23, 447-55.
33. Reynolds,M., Peterson,E., Quievryn,G. and Zhitkovich,A. (2004) Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem. 279, 30419-30424.
34. Zhitkovich,A., Voitkun,V. and Costa,M. (1996) Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry, 35, 7275-7282.
35. Stearns,D.M., Kennedy,L.J., Courtney,K.D., Giangrande,P.H., Phieffer,L.S. and Wetterhahn,K.E. (1995) Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry, 34, 910-919.
36. Peterson-Roth,E., Reynolds,M., Quievryn,G. and Zhitkovich,A. (2005) Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol. Cell. Biol., 25, 3596-3607.
37. Zhitkovich,A., Peterson-Roth,E, and Reynolds,M. (2005) Killing of chromium-damaged cells by mismatch repair and its relevance to carcinogenesis. Cell Cycle, 4, 1050-1052.